Table 1.
Comparison between the interviewed immigrants in the study and all immigrants with tuberculosis diagnosed in 2005
| Immigrant TB patients in 2005, N (%)* | Study population, N (%)* | P-value Chi-square | |
| Total | 762 (100) | 60 (100) | |
| Sex | 0.49 | ||
| Male | 448 (59) | 38 (63) | |
| Female | 314 (41) | 22 (37) | |
| Age (yr) | 0.08 | ||
| 18–24 | 150 (20) | 18 (30) | |
| 25–44 | 386 (51) | 33 (55) | |
| 45–64 | 154 (20) | 8 (13) | |
| ≥ 65 | 71 (9) | 1 (2) | |
| Unknown | 1 (0) | 0 (0) | |
| Generation | 0.43 | ||
| First generation immigrant | 718 (94) | 58 (97) | |
| Second generation immigrant | 44 (6) | 2 (3) | |
| Region of origin | 0.44 | ||
| Europe | 92 (12) | 3 (5) | |
| America (Central and South) | 72 (9) | 6 (10) | |
| America (North) | 1 (0) | 0 (0) | |
| Asia | 249 (33) | 18 (30) | |
| Africa | 338 (44) | 33 (55) | |
| Unknown | 10 (1) | 0 (0) | |
| Localisation of TB | 0.69 | ||
| Pulmonary | 357 (47) | 31 (52) | |
| Extrapulmonary | 305 (40) | 23 (38) | |
| Pulmonary and extrapulmonary | 100 (13) | 6 (10) | |
| Culture result | 0.83 | ||
| Positive | 531 (70) | 44 (73) | |
| Negative | 91 (12) | 6 (10) | |
| Not done/unknown | 140 (18) | 10 (17) | |
| Previously diagnosed with TB | 0.13 | ||
| No | 611 (80) | 54 (90) | |
| Yes | 46 (6) | 3 (5) | |
| Unknown | 105 (14) | 3 (5) | |
| Treatment regime | < 0.01 | ||
| Standard (4HRZ(E)/2HR(E)) | 542 (71) | 43 (72) | |
| Other | 220 (29) | 9 (15) | |
| Unknown | 0 (0) | 8 (13) | |
| Impaired immunity | < 0.01 | ||
| No | 282 (37) | 40 (67) | |
| Yes | 140 (18) | 4 (7) | |
| Missing | 340 (45) | 16 (27) | |
| Hospitalization (during TB treatment for at least 7 days) | 0.16 | ||
| No | 438 (58) | 29 (48) | |
| Yes | 232 (30) | 19 (32) ‡ | |
| Unknown | 92 (12) | 12 (20) |
Definition of abbreviations: H = isoniazid; R = rifampin; Z = pyrazinamid; E = ethambutol;
* Column percentages are given
‡ This number differs from that in Table 2 because a different definition for hospitalization is used in the NTR-database.